The Elephant in the Room: Johnson & Johnson's Talc Controversy The proposed $5.
5 billion settlement between Johnson & Johnson (J&J) and thousands of plaintiffs alleging that its talc based products cause ovarian cancer has sparked a mix of reactions, ranging from relief to outrage.
J&J dismisses these claims as meritless, but it's clear that this saga has exposed deep seated concerns about consumer safety and corporate accountability.